GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug conjugate (ADC), GSK’227 has gained priority medicines (PRIME) ...

Joe Leach, MD, discusses how comprehensive biomarker testing has impacted treatment selection for patients with small cell lung cancer. Joe Leach, MD, medical oncologist, associate medical director ...

Imfinzi was approved by the FDA for the treatment of adults with limited-stage small cell lung cancer without disease ...

The agency granted approval to durvalumab for the treatment of a subset of patients with limited-stage small cell lung cancer ...

The approval of durvalumab, based on data from the phase 3 ADRIATIC study, offers a new standard of care for patients with ...

During Ms Lee’s hospital stay in 2016, doctors arranged for a biopsy, followed by genetic testing on a cancer-stricken lymph node to check for mutations causing non-small cell lung cancer (NSCLC).

The phase 3 trial found adding the TIGIT candidate tiragolumab to Roche's approved checkpoint inhibitor had no effect on overall survival (OS) in non-small cell lung cancer (NSCLC). Investigators ...

YouTube has shared a final blog post from Susan Wojcicki, the company’s former CEO and one of Google’s earliest employees, detailing her unexpected diagnosis and two-year battle with lung cancer.

radon – and those are kind of rare and maybe make up a small portion,” she said. “And then there are mutations that cause lung cancer, and we are also seeing a really significant increase in ...

An immediate full-body PET Scan showed she had stage 4, inoperable lung cancer that had spread to her adrenal glands and brain. “I am a big believer in early screening and advocating for ...

To understand these complex interactions, we measure the density of different cell types in the stroma using immunohistochemistry techniques on tumor samples from lung cancer patients ... can be ...